• Clinical science

Deep vein thrombosis (Phlebothrombosis)

Summary

Deep vein thrombosis (DVT) is the formation of a blood clot in a deep vein of the legs, thigh, or pelvis. Thrombosis is most often seen in individuals with a history of immobilization, obesity, malignancy, or hereditary thrombophilia. Vascular endothelial damage, venous stasis, and hypercoagulability, collectively referred to as the Virchow triad, are the main factors contributing to the development of DVT. Symptoms usually occur unilaterally and include swelling, tenderness, and redness or discoloration. Pulmonary embolism (PE), a severe complication of DVT, should be suspected in patients with dizziness, dyspnea, and fever. The diagnostic test of choice for DVT is compression ultrasound. In most cases, a negative D-dimer test allows thrombosis or PE to be ruled out, but a positive test is nonspecific. Initial acute treatment of DVT consists of anticoagulation with heparin and, if the thrombus is large or unresponsive to anticoagulation, may also include thrombolysis or thrombectomy. Secondary prophylaxis is achieved with oral warfarin or direct factor Xa inhibitors and supportive measures such as regular exercise and compression stockings.

Etiology

Risk factors for deep vein thrombosis

  • History of DVT or PE (30x increased risk) [1]
  • Immobilization: e.g., post-surgery, long-distance flights, trauma (20x increased risk)
  • Age > 60 years
  • Malignancy
  • Hereditary thrombophilia (especially factor V Leiden)
  • Pregnancy, estrogen use (oral contraceptives)
  • Obesity
  • Smoking
  • Insufficient thrombosis prophylaxis, noncompliance with prophylaxis

References:[2][3]

Pathophysiology

The Virchow triad

The Virchow triad refers to the three main pathophysiological components of thrombus formation.

  1. Hypercoagulability: increased platelet adhesion, increased clotting tendency (thrombophilia)
  2. Endothelial damage: inflammatory, traumatic
  3. Stasis (venous): varicosis, external pressure on the extremity, immobilization, local application of heat

To remember the three pathophysiological components of thrombus formation, think: “HE'S Virchow”: H-Hypercoaguability, E-Endothelial damage, S-Stasis.

References:[2][4][5]

Clinical features

  • May be asymptomatic
  • Localized unilateral symptoms
    • Typically affects deep veins of the legs, thighs, or pelvis
      • More common in the left lower extremity
      • May-Thurner syndrome: compression of the left iliac vein between the right iliac artery and a lumbar vertebral spur (occurs in > 20% of adults) [6][7]
    • Swelling, feeling of tightness or heaviness
    • Warmth, erythema, and possibly livid discoloration
    • Progressive tenderness, dull pain
      • Homan sign: calf pain on dorsal flexion of the foot
      • Meyer sign: Compression of the calf causes pain.
      • Payr sign: plantar pain triggered by pressure on the medial foot sole
    • Distention of superficial veins
    • Distal pulses are normal
  • General symptoms: fever [8]
  • Possible signs of pulmonary embolism: dyspnea, chest pain, dizziness, weakness

References:[2][9]

Subtypes and variants

Phlegmasia cerulea dolens

  • Definition: : a severe form of phlebothrombosis, characterized by obstruction of all veins of one extremity with subsequent restriction of arterial flow; and associated with a high mortality
  • Symptoms
    • Severe swelling, edema, and pain
    • Coldness, cyanosis, and pulselessness
  • Treatment
    • Emergency surgery: venous thrombectomy, fasciotomy
    • Fibrinolysis if surgery fails
    • Amputation as last resort
  • Complications: shock, gangrene, acute renal failure (due to rhabdomyolysis)

Paget-Schroetter disease (upper extremity DVT)

References:[10][11]

Diagnostics

The diagnostic approach for suspected DVT is determined by the Wells score. Compression ultrasonography and D-dimer levels are the main diagnostic tests.

Wells criteria for deep vein thrombosis

The Wells score for DVT identifies the probability of DVT. A different version of the score may be used to determine the probability of PE (see Wells criteria for PE).

Criteria Score
Medical history Active cancer +1
Previously documented DVT +1
Immobilization Paralysis or recent (cast) immobilization of lower extremity +1
  • Recently bedridden (≥ 3 days) or
  • Major surgery (< 12 weeks)
+1
Clinical symptoms Tenderness localized along the deep venous system +1
Swelling of the entire leg +1
Calf swelling ≥ 3 cm compared to asymptomatic calf +1
Unilateral pitting edema in symptomatic leg +1
Presence of collateral (non-varicose) superficial veins +1
Differential diagnosis Alternative diagnosis at least as likely as DVT -2

Interpretation

  • 2 risk group
    • < 2: DVT unlikely (low risk)
    • ≥ 2: DVT likely (high risk)
  • OR 3 risk group
    • 0: low risk
    • 1–2: moderate risk of DVT
    • ≥ 3: high risk of DVT

Compression ultrasonography with Doppler (test of choice)

  • Definition: A combination of ultrasonography (to visualize the vein) and Doppler (to assess blood flow abnormalities) in which the examiner applies pressure using the ultrasound probe.
  • High sensitivity and specificity, but very operator dependent
  • Indications: DVT should be suspected in veins (of the extremities) that can be compressed by the ultrasound probe.
    • High sensitivity for DVT in popliteal and femoral veins
    • Duplex ultrasonography without compression is used to assess DVT in the iliac veins.
  • Findings: noncompressibility of the obstructed vein, visible hyperechoic mass, absent or abnormal flow in Doppler imaging

D-dimer testing

  • High sensitivity (∼ 95%), low specificity (∼ 50%)
  • Useful for ruling out DVT (normal D-dimer levels rule out DVT)
  • Elevated D-dimers alone are not proof of DVT.

Further diagnostic tests

  • Venography: (angiography)
    • Most accurate assessment of calf veins and valvular competency
    • Indications: obesity, severe edema, equivocal results in previous tests
  • CT scan: : suspected pulmonary embolism or underlying malignancy
  • Thrombophilia screening (coagulation studies)
    • Indications: young patients, unusual thrombus localization, positive family history
    • At earliest, tests should be performed 2 weeks after discontinuing anticoagulation.
  • General tumor screening

References:[12][13][14][15][16][17][18]

Differential diagnoses

Superficial thrombophlebitis

  • Definition: Inflammation and thrombosis of a superficial vein, most commonly in the leg. It may co-exist with DVT, and it rarely causes PE.
  • Risk factors: same as for DVT (see risk factors for deep vein thrombosis above), but also
  • Variants
  • Clinical features: pain, tenderness, induration, and erythema overlying a superficial vein, often with a palpable cord (the thrombosed vein)
  • Diagnostics
    • Typically a clinical diagnosis
    • Duplex ultrasound
      • Indicated if the clinical diagnosis is not clear
      • Findings: A thickened, edematous, noncompressible vessel with or without an intraluminal thrombus
    • Tests to diagnose the underlying cause: See “Further diagnostic tests” under “Diagnostics” above.
  • Treatment
    • Symptomatic: NSAIDs, compression, elevation of the affected limb
    • Anticoagulation (e.g., LMWH, fondaparinux) if larger segments of the vein (≥ 5cm) are affected
    • DVT treatment if the thrombus is close to the junction with the deep venous system (see “Treatment” below)
  • Complications
    • Extension into the deep veins → DVT
    • Infection (septic thrombophlebitis)
    • Distal embolization (PE)

Other differential diagnoses of DVT

References:[20][15][21][22]

The differential diagnoses listed here are not exhaustive.

Treatment

Anticoagulation

  • Acute therapy
  • Secondary prophylaxis
    • Warfarin with target therapeutic INR of 2.0–3.0
      • Duration of treatment
        • First thrombosis: usually 3–6 months
          • For life (or until cured) in malignant disease
          • For 6 months, possibly for life, for confirmed thrombophilia
          • For at least 3 months, possibly for life (if there is no increased risk of bleeding), for idiopathic distal thrombosis
          • For 3 months in case of temporary risk factor (e.g., surgery, immobility)
        • For confirmed thrombophilia and recurrent thrombosis: indefinite
    • OR direct oral factor Xa inhibitor (i.e., rivaroxaban, apixaban)
      • Regular monitoring of coagulation parameters not required → improved patient compliance
      • Duration of treatment: at least 3 months

Additional therapy

  • Thrombolysis
    • Goal: faster resolution of thrombi
    • Indications
      • Slow response to anticoagulation
      • Pulmonary embolism with hemodynamic instability
      • Can be considered for acute proximal DVT of the leg
    • Agents: streptokinase, urokinase, tissue plasminogen activator
    • Catheter-directed thrombolysis: The thrombolytic agent is administered directly at the site of obstruction via a venous catheter.
  • Thrombectomy
    • Intravenous thrombus removal via a catheter
    • Indications
    • Low-dose heparin is required prior to the procedure.
  • Inferior vena cava filter : (Greenfield filter): indicated in patients with DVT at high risk of developing pulmonary embolism who have contraindications to anticoagulation, thrombolysis, and thrombectomy (e.g., postoperative patients)
  • Compression therapy with bandages or stockings
  • Early mobilization as early as tolerated, minimize bedrest.

References:[12][23][24][2][4][25][26][27]

Complications

References:[2]

We list the most important complications. The selection is not exhaustive.

Prevention

  • Preventive measures
  • Indications (based on assessment of risk factors; see “Etiology” above)
    • Low thrombosis risk: exercise, compression stockings
    • Medium and high thrombosis risk: anticoagulation treatment

References:[28][2]